Areterna's Messengers

mRNA-LNP Encapsulation Service

To ensure effective in vivo delivery, mRNA vaccines rely on not only optimized antigen sequences but also a robust delivery system capable of overcoming extracellular barriers, facilitating endosomal escape, and evading intracellular immune responses. Lipid...

Fluc-eGFP mRNA, Dual-Reporter for Protein Expression

In recent years, mRNA vaccines and drugs have received widespread attention around the world. Areterna LLC is proud to introduce Fluc-eGFP mRNA (Catalog number: 11013-CAP), a cutting-edge tool to accelerate your mRNA research. This mRNA encodes both eGFP and...

dsRNA: an unwanted byproduct from mRNA IVT

In vitro transcription (IVT) remains the predominant method for large-scale mRNA synthesis due to its efficiency and scalability. However, a significant challenge associated with IVT is the residual double-stranded RNA (dsRNA) produced as a by-product. This dsRNA can...

Why Co-Transcriptional Capping

In-vitro transcription (IVT) is a reactor-based scheme to manufacture RNA where cell-derived impurities or adventitious contaminants can be avoided thus making the manufacturing process GMP-friendly. The IVT reaction is often carried out at 37°C for 2...

Enzymatic Capping: Process, Pros, and Cons

We have discussed the evolution of cap analogs and the new generation of fine-tuned cap analogs for different applications. Generally, there are two ways of capping mRNA produced from an IVT reaction. One way is co-transcriptionally capping where a cap analog is added...

AI-Assisted Cap Analog Discovery Platform

We discussed our novel cap analogs, CAP4 and CAP5, in the last blog The Evolution of Cap Analogs, you may wonder how we discovered these unique molecules. Areterna’s engine of innovation is built upon our AI-Assisted Cap Analog Discovery Platform which integrates a...

The Evolution of Cap Analogs

Introduction In the intricate world of mRNA synthesis, the cap structure plays a pivotal role in regulating gene expression. Scientists have made significant strides in the development of various cap analogs to enhance mRNA stability, translational efficiency, and...